Emas Pharma

Bionical acquires Global CRO Emas Pharma

Monday, November 14, 2016

Bionical, the integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, has announced the strategic acquisition of Emas Pharma, a global CRO. Emas, which provides pharmaceutical development and clinical research services to biotech, medical device and specialized pharmaceutical companies worldwide, will join Bionical’s existing fast growing clinical services business. Financials were not disclosed.

[Read More]